159 related articles for article (PubMed ID: 51028)
1. Hyperthyroidism in Tasmania following iodide supplementation: measurements of thyroid-stimulating autoantibodies and thyrotropin.
Adams DD; Kennedy TH; Stewart JC; Utiger RD; Vidor GI
J Clin Endocrinol Metab; 1975 Aug; 41(2):221-8. PubMed ID: 51028
[TBL] [Abstract][Full Text] [Related]
2. Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.
Chopra IJ; Solomon DH; Johnson DE; Chopra U; Fischer DA
J Clin Endocrinol Metab; 1970 Apr; 30(4):524-8. PubMed ID: 5435290
[No Abstract] [Full Text] [Related]
3. Pituitary-thyroid function in thyrotoxic patients in relation to long-acting thyroid stimulator (LATS) levels.
Fukuchi M; Matsuoka T; Inoue T; Miyai K; Kumahara Y
Acta Endocrinol (Copenh); 1970 Dec; 65(4):577-82. PubMed ID: 5536685
[No Abstract] [Full Text] [Related]
4. Clinical study on early changes in thyroid function of hyperthyroidism treated with propylthiouracil and a relatively small dose of iodide.
Kasai K; Suzuki H; Kikuchi T; Ieiri T; Takemura Y
Endocrinol Jpn; 1976 Aug; 23(4):347-54. PubMed ID: 1024041
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.
Celani MF; Bonati ME; Stucci N
Diabetes Res; 1994; 27(1):15-25. PubMed ID: 7648793
[TBL] [Abstract][Full Text] [Related]
6. [TSH and the "long-acting thyroid stimulator" (LATS) in patients with compensated hyperthyroidism].
zur Mühlen A von ; Hesch RD; von Lilienfeld H; Emrich D
Acta Endocrinol Suppl (Copenh); 1971; 152():86. PubMed ID: 5313711
[No Abstract] [Full Text] [Related]
7. Physiological states and functional relation between thyrotropin and free thyroxine in thyroid health and disease: in vivo and in silico data suggest a hierarchical model.
Midgley JE; Hoermann R; Larisch R; Dietrich JW
J Clin Pathol; 2013 Apr; 66(4):335-42. PubMed ID: 23423518
[TBL] [Abstract][Full Text] [Related]
8. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
[No Abstract] [Full Text] [Related]
9. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
Lamberg BA; Gordin A
Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
[No Abstract] [Full Text] [Related]
10. Dissociation between iodide-induced thyroiditis and antibody-mediated hyperthyroidism in NOD.H-2h4 mice.
McLachlan SM; Braley-Mullen H; Chen CR; Aliesky H; Pichurin PN; Rapoport B
Endocrinology; 2005 Jan; 146(1):294-300. PubMed ID: 15459116
[TBL] [Abstract][Full Text] [Related]
11. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of LATS and TSH in the blood.
Lemarchand-Béraud T; Griessen M; Scazziga BR
Ann Clin Res; 1972 Jun; 4(3):121-37. PubMed ID: 4625026
[No Abstract] [Full Text] [Related]
13. The pathogenesis of thyrotoxicosis the discovery of LATS.
Adams DD
N Z Med J; 1975 Jan; 81(531):15-7. PubMed ID: 1055308
[No Abstract] [Full Text] [Related]
14. Effects of chronic hemodialysis on thyroid function in chronic renal failure.
Silverberg DS; Ulan RA; Fawcett DM; Dossetor JB; Grace M; Bettcher K
Can Med Assoc J; 1973 Aug; 109(4):282-6. PubMed ID: 4125852
[TBL] [Abstract][Full Text] [Related]
15. Correlation between long-acting thyroid stimulator protector level and thyroid 131-I uptake in thyrotoxicosis.
Adams DD; Kennedy TH; Stewart RD
Br Med J; 1974 Apr; 2(5912):199-201. PubMed ID: 4406686
[TBL] [Abstract][Full Text] [Related]
16. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
[TBL] [Abstract][Full Text] [Related]
17. [Thyroid function and thyroid autoimmunity at the late pregnancy: data from 664 pregnant women].
Guan HX; Li CY; Li YS; Fan CL; Teng Y; Ouyang YH; Cong Q; Teng WP
Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):529-32. PubMed ID: 17083836
[TBL] [Abstract][Full Text] [Related]
18. Temporal trends in thyroid-stimulating hormone (TSH) and thyroid peroxidase antibody (ATPO) testing across two phases of iodine fortification in Tasmania (1995-2013).
Hong A; Stokes B; Otahal P; Owens D; Burgess JR
Clin Endocrinol (Oxf); 2017 Oct; 87(4):386-393. PubMed ID: 28500624
[TBL] [Abstract][Full Text] [Related]
19. Clinical study on early changes in thyroid function of hyperthyroidism treated with propylthiouracil and a relatively small dose of iodide.
Kasai K; Suzuki H; Kikuchi T; Ieiri T; Takemura Y
Endocrinol Jpn; 1977 Aug; 23(4):347-54. PubMed ID: 923523
[No Abstract] [Full Text] [Related]
20. Reciprocal relation of thyroid-stimulating hormone and thyroid-stimulating immunoglobulin in a patient with endogenous subclinical hyperthyroidism.
Premachandra BN; Radparvar A; Williams IK
Am J Med Sci; 2007 May; 333(5):296-9. PubMed ID: 17505173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
